Biotech | April 13, 2022
Novel Covid-19 vaccine may protect the immunocompromised
The peptide-based vaccine induces a t cell-dependent response
The peptide-based vaccine induces a t cell-dependent response
The total investment is in the region of Rs 200 crore
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
The expansion positions Cambrex with the largest and most advanced API facility in the United States
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Subscribe To Our Newsletter & Stay Updated
